These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6109821)
21. Food and Drug Administration Advisory Committee on Protocols for Safety Evaluations. Panel on reproduction report on reporduction studies in the safety evaluation of food additives and pesticide residues. Toxicol Appl Pharmacol; 1970 Jan; 16(1):264-96. PubMed ID: 5467148 [No Abstract] [Full Text] [Related]
22. Priority-based assessment of food additives database of the U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition. Benz RD; Irausquin H Environ Health Perspect; 1991 Dec; 96():85-9. PubMed ID: 1820284 [TBL] [Abstract][Full Text] [Related]
23. Food and Drug Administration risk assessment--process and toxicologic pathology. Moch RW; Dua PN; Hines FA Toxicol Pathol; 1997; 25(1):61-7. PubMed ID: 9061853 [TBL] [Abstract][Full Text] [Related]
24. Research activities in toxicology and toxicological requirements of the FDA for food and color additives. Green S Biomed Environ Sci; 1988 Dec; 1(4):424-30. PubMed ID: 3077268 [TBL] [Abstract][Full Text] [Related]
25. FDA's priority-based assessment of food additives. II. General toxicity parameters. Rulis AM; Hattan DG Regul Toxicol Pharmacol; 1985 Jun; 5(2):152-74. PubMed ID: 3839589 [TBL] [Abstract][Full Text] [Related]
26. Comment on "Revisiting the carrageenan controversy: do we really understand the digestive fate and safety of carrageenan in our foods?" by S. David, C. S. Levi, L. Fahoum, Y. Ungar, E. G. Meyron-Holtz, A. Shpigelman and U. Lesmes, Food Funct., 2018, 9, 1344-1352. Weiner ML; McKim JM Food Funct; 2019 Mar; 10(3):1760-1762. PubMed ID: 30794268 [TBL] [Abstract][Full Text] [Related]
27. Evidence for the safety of gum arabic (Acacia senegal (L.) Willd.) as a food additive--a brief review. Anderson DM Food Addit Contam; 1986; 3(3):225-30. PubMed ID: 3743831 [TBL] [Abstract][Full Text] [Related]
28. FDA'S food ingredient approval process: Safety assurance based on scientific assessment. Rulis AM; Levitt JA Regul Toxicol Pharmacol; 2009 Feb; 53(1):20-31. PubMed ID: 18983884 [TBL] [Abstract][Full Text] [Related]
29. Food and Drug Administration: approach to evaluating neurotoxicity. Sobotka TJ Toxicol Ind Health; 1989 Mar; 5(2):157-64. PubMed ID: 2728012 [TBL] [Abstract][Full Text] [Related]
30. The danger in food safety policies. Hall RH Can Med Assoc J; 1978 Jan; 118(1):83-7. PubMed ID: 620390 [No Abstract] [Full Text] [Related]
31. Health update on sulfites in food and drugs. Oberste DM J Ark Med Soc; 1984 Jul; 81(2):130-2. PubMed ID: 6236206 [No Abstract] [Full Text] [Related]
32. Food safety as seen by an epidemiologist. Riche WH Le Can Med Assoc J; 1968 Jul; 99(1):22-7. PubMed ID: 5663002 [No Abstract] [Full Text] [Related]
34. Criteria for deciding the need for chronic testing -- a regulatory viewpoint. Robens JF Vet Hum Toxicol; 1979 Dec; 21(6):427-30. PubMed ID: 532082 [No Abstract] [Full Text] [Related]
35. Living with and reforming the Delaney Clause. Degnan FH; Flamm WG Food Drug Law J; 1995; 50(2):235-56. PubMed ID: 10342993 [No Abstract] [Full Text] [Related]
37. Trail of toxins leads through conference rooms in Dallas. Stone R Science; 1994 Apr; 264(5156):204. PubMed ID: 8146648 [No Abstract] [Full Text] [Related]
38. Current developments in food additive toxicology in the USA. Hattan DG; Kahl LS Toxicology; 2002 Dec; 181-182():417-20. PubMed ID: 12505345 [TBL] [Abstract][Full Text] [Related]
39. Pro-apoptotic action of macrophage inhibitory cytokine 1 and counteraction of activating transcription factor 3 in carrageenan-exposed enterocytes. Choi HJ; Kim HG; Kim J; Park SH; Park J; Oh CG; Do KH; Lee SJ; Park YC; Ahn SC; Kim YS; Moon Y Toxicol Lett; 2014 Nov; 231(1):1-8. PubMed ID: 25180886 [TBL] [Abstract][Full Text] [Related]